Reporting owner
Zawitz David
Reporting owner CIK 0002046750 · Chief Operating Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Zawitz David | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Zawitz David | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Verrica Pharmaceuticals Inc.VRCA · company listings | Zawitz DavidChief Operating Officer | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 2,500 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Verrica Pharmaceuticals Inc.VRCA · company listings | Zawitz DavidChief Operating Officer | PurchaseCommon StockNon-derivative security · Code P | 10,000 | 4.2425Value: 42,425Currency not specified | View ↗ |
2 transactions on this page. Filing date, newest first.